# A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile

> **NCT07649096** · PHASE1 · NOT_YET_RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 56 (estimated)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **BIOLOGICAL:** FZ002
- **OTHER:** Placebo for FZ002

## Key facts

- **NCT ID:** NCT07649096
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-17
- **Primary completion:** 2028-08-22
- **Final completion:** 2028-09-22
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07649096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07649096, "A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07649096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*